THE PATHOGENIC EFFECTS OF MYCOBACTERIUM HAEMOPHILUM IN IMMUNOSUPPRESSED ALBINO MICE

References

1. Claman H. N. 1972; Corticosteroids and lymphoid cells. New Engl. J. Med. 287:388
   [Google Scholar]
2. Cowan S. T. 1974 Cowan and Steele’s Manual for the identification of medical bacteria Cambridge University Press: Cambridge; p 59
   [Google Scholar]
3. Cruickshank R. 1965 Medical microbiology 11th ed Churchill Livingstone; Edinburgh: pp 632 and 749
   [Google Scholar]
4. Dawson D. J., Jennis F. 1980; Mycobacterium with a growth requirement for ferric ammonium citrate identified as Mycobacterium haemophilum. J. clin. Microbiol 11:90
   [Google Scholar]
5. Fenner F., Martin S. P., Pierce C. H. 1949; The enumeration of viable tubercle bacilli in cultures and infected tissues. Ann. N. Y. Acad. Sci 52:751
   [Google Scholar]
6. Hobby G.L., Lenert T. F. 1971; Cross immunity between mycobacterial and Pseudomonas pseudomallei infections in mice. Am. Rev. resp. Dis 103:569
   [Google Scholar]
7. Holm J., Lester V. 1942; Diagnostic demonstration of tubercle bacilli. Acta tuberc. scand 16:310
   [Google Scholar]
8. MacCallum P., Tolhurst J. C., Buckle G., Sissons H. A. 1948; A new mycobacterial infection in man. J. Path. Bact 60:93
   [Google Scholar]
9. Mackaness G. B. 1964; The immunological basis of acquired cellular resistance. J. exp. Med 120:105
   [Google Scholar]
10. Mezo A., Jennis F., McCarthy S. W., Dawson D. J. 1979; Unusual mycobacteria in 5 cases of opportunistic infection. Pathology 11:377
    [Google Scholar]
11. Pierce-Chase C. H., Fauve R. M., Dubos R. 1964; Corynebacterial pseudotuberculosis in mice. I. Comparative susceptibility of mouse strains to experimental infection with Corynebacterium kutscheri. J. exp. Med 120:267
    [Google Scholar]
12. Quittner H., Wald N., Sussman L. N., Antopol W. 1951; The effect of massive doses of cortisone on the peripheral blood and bone marrow of the mouse. Blood 6:513
    [Google Scholar]
13. Rees R. J. W. 1965; Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad. Int. J. Lepr 33:646
    [Google Scholar]
14. Shepard C. C. 1965; Temperature optimum of Mycobacterium leprae in mice. J. Bad 90:1271
    [Google Scholar]
15. Shepard C. C., Habas J. A. 1967; Relation of infection to tissue temperature in mice infected with Mycobacterium marinum and Mycobacterium leprae. J. Bact 93:790
    [Google Scholar]
16. Shepard C. C., McCrae D. H. 1965; Mycobacterium leprae in mice: minimal infectious dose, relationship between staining quality and infectivity and effect of cortisone. J. Bact 89:365
    [Google Scholar]
17. Sher N. A., Chaparas S. D., Greenberg L. E., Bernard S. 1975; Effects of BCG, Corynebacterium parvum and methanol-extraction residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice. Infect. Immun 12:1325
    [Google Scholar]
18. Sompolinsky D., Lagziel A., Naveh D., Yankilevitz T. 1978; Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int. J. syst. Bact 28:67
    [Google Scholar]
19. Tabbara K. F., O’Connor G. R., Nozik R. A. 1975; Effect of immunization with attenuated Mycobacterium bovis on experimental toxoplasmic retinochoroiditis. Am. J. Ophthal 79:641
    [Google Scholar]
20. Tonelli G. 1966; Acute toxicity of corticoids in the mouse. Steroids 8:857
    [Google Scholar]
21. Walder B. K., Jeremy D., Charlesworth J. A., Macdonald G. J., Pussell B. A., Robertson M. R. 1976; The skin and immunosuppression. Aust. J. Derm 17:94
    [Google Scholar]